Abstract:The concept of pharmaceutical care (PC) has existed as a professional philosophy for more than 30 years. However, for a long period of time, little had been done for its integration into the regular practice of healthcare provision. The COVID-19 pandemic and the resulting increase in patient influx in the community pharmacies (CP) encouraged the exploration and establishment of new healthcare services provided within the CP. Nevertheless, these services of PC are still novel, and more can be done to expand the community pharmacists' current role in primary healthcare. This can be achieved by improving and expanding the newly established services, all while incorporating new ones, for the benefit of public health and the reduction of avoidable healthcare expenditures. This article reviews information about the benefits of this service regarding patient health and the reduction of financial expenses pertinent to adverse drug events within the setting of the CP. Adverse drug events account for significant healthcare expenses and patient distress due to relevant symptoms, emergency doctor visits, and increased hospitalization rates. Several studies conducted internationally have investigated the positive impact of PC practiced by community pharmacists. In spite of results sometimes presenting a non-continuous pattern, PC applied under specific conditions has tangible positive outcomes. Congestive heart failure and type 2 diabetes mellitus patients presented fewer hospital admissions, better symptom control, and higher adherence in comparison to control groups, while a study on asthma patients revealed improved inhalation techniques. All intervention groups reported psychological improvement and a better understanding of their treatment. Special reference is made to the importance of this service for patients receiving anti-cancer treatment and how community pharmacists can have a crucial role in designing, monitoring, and re-designing these therapeutic schemes whose complexity and related adverse drug events negatively affect patient adherence. The role of community pharmacists was very important, especially for primary care, for both patients and healthcare systems during the pandemic, and it seems that it will remain decisive in the post-COVID era as well. The increased complexity of therapy and polypharmacy creates the need for organized, active participation of pharmacists in healthcare provision so that they can use their knowledge and skills under continuous cooperation with other healthcare professionals, thus providing coordinated services for the benefit of the patient.

The role of the hospital pharmacist to guarantee access and continuity of care for the management of epilepsy

Community Pharmacist-Centered training program improves confidence in delivering epilepsy care

Building a pediatric neurocritical care program: The role of the clinical pharmacist practitioner on clinical practice and education. A curriculum for neuropharmacology training

The management of epilepsy in children and adults

Role of pharmaceutical care in therapeutic regimens within the community pharmacy

Effect of Pharmaceutical Care on the Treatment Outcomes of Epilepsy

Medical management of epileptic seizures: challenges and solutions

Pharmaceutical care for a patient with infection complicating with epilepsy from clinical pharmacist

Unmet needs of people with epilepsy: A qualitative study exploring their journey from presentation to long-term management across five European countries

The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies

A Comprehensive Review of Emerging Trends and Innovative Therapies in Epilepsy Management

Managing epilepsy in the primary care network in Brazil: are health professionals prepared?]

Health equity integrated epilepsy care and research: A narrative review

Evaluation of drug safety in pediatric epileptic patients: A prospective interventional study with clinical pharmacist intervention at a tertiary care teaching hospital

Integrating Network Neuroscience Into Epilepsy Care: Progress, Barriers, and Next Steps

Treatment gaps and challenges in epilepsy care in the Philippines

Drug therapy problems and contributing factors among patients with epilepsy

Interictal psychosis of epilepsy: What is the role of the neurologist?

The Role of Clinical Pharmacists in Patient-Centric Comprehensive Multiple Sclerosis Care

Anti-seizure Medications: Challenges and Opportunities

The consequences of refractory epilepsy and its treatment